CA23256X1006 - CYBN - A2QJAV (XTSE)
CYBIN INC Aktie
14,32 CAD
Aktuelle Kurse von CYBIN INC
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NYSE |
CYBN
|
USD
|
21.12.2024 01:53
|
9,95 USD
| 9,59 USD | 3,75 % |
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,03 % | 1,52 % | 4,03 % | 15,98 % | 4,04 % | -30,87 % | -78,25 % |
Company Profile for CYBIN INC Share
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.
Company Data for CYBIN INC Share
Name CYBIN INC
Company Cybin Inc.
Symbol CYBN
Website https://www.cybin.com
Primary Exchange
TSX
WKN A2QJAV
ISIN CA23256X1006
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Douglas L. Drysdale
Market Capitalization 194 Mio
Country Canada
Currency CAD
Employees 0,1 T
Address 100 King Street West, M5X 1C9 Toronto
IPO Date 2019-09-13
Stock Splits
Date | Split |
---|---|
19.09.2024 | 1:38 |
Ticker Symbols
Name | Symbol |
---|---|
Frankfurt | R7E1.F |
NYSE | CYBN |
More Shares
Investors who CYBIN INC hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.